[admin]

Sanofi-Aventis SA's (SASY.PA: Quote, Profile, Research, Stock Buzz) drug Acomplia can significantly improve blood sugar control in patients with type 2 diabetes who are not adequately controlled with insulin therapy, the French drugmaker said on Tuesday.

But patients on the drug are more likely to suffer from anxiety and depression, according to clinical trial results presented at the American Diabetes Association annual meeting in San Francisco.........

http://www.reuters.com/article/marketsN ... 6820080610